Agents affecting thrombosis and hemostasis
US5968897A · kind A · utility
2Cited by
9References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 1998 |
| Grant date | Oct 19, 1999 |
| Priority date | — |
| Expiry date | Jan 30, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/83
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilic conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.